
==== Front
Rev Cardiovasc Med
Rev Cardiovasc Med
RCM
Reviews in Cardiovascular Medicine
1530-6550
2153-8174
IMR Press

10.31083/j.rcm2508306
S1530-6550(24)01443-1
Review
Idiopathic Ventricular Fibrillation — Just How Much Idiopathic is it?
Lietava Samuel 1
Sepsi Milan 1 * sepsi.milan@fnbrno.cz

Novotny Tomas 1
Airaksinen Juhani Academic Editor
1Department of Internal Medicine and Cardiology, University Hospital Brno and Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic
*Correspondence: sepsi.milan@fnbrno.cz (Milan Sepsi)
22 8 2024
8 2024
25 8 30623 2 2024
22 4 2024
30 4 2024
Copyright: © 2024 The Author(s). Published by IMR Press.
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY 4.0 license.
Idiopathic ventricular fibrillation is diagnosed in survivors of sudden cardiac death that has been caused by ventricular fibrillation without known structural or electrical abnormalities, even after extensive investigation. It is a common cause of sudden death in young adults. Although idiopathic ventricular fibrillation is a diagnosis of exclusion, in many cases only a partial investigation algorithm is performed. The aim of this review is to present a comprehensive diagnostic evaluation algorithm with a focus on diagnostic assessment of inherited arrhythmic syndromes and genetic background.

idiopathic ventricular fibrillation
sudden cardiac death
arrhythmic syndrome
sudden cardiac death
long QT syndrome
Brugada syndrome
catecholaminergic polymorphic ventricular tachycardia
==== Body
pmc1. Introduction

Sudden death is a serious medical problem even in modern society. It is defined as a witnessed, non-traumatic and unexpected fatal event occurring within 1 hour of the onset of symptoms in an apparently healthy individual, or an unwitnessed death occurring within 24 hours after the individual was seen in good health [1]. If a cardiac cause is presumed as the reason for sudden death, or an autopsy has identified a cardiac anomaly as the probable cause of death (or in the absence of any obvious extra-cardiac causes at the post-mortem examination), it is referred to as sudden cardiac death (SCD) [2].

In Europe, SCD is the cause of death in 10–20% of all deaths, which equates to 300,000 individuals in Europe each year. The incidence of SCD differs according to age. It is very rare in childhood (1 per 100,000 person-years) [3, 4, 5], while in middle-aged individuals the incidence is 50 per 100,000 person-years [6, 7, 8]. The highest incidence is in the population over 80 years of age (200 per 100,000 person-years) [8]. The etiology of SCD depends on the age of the individual. In the elderly, ischemic heart disease and heart failure is the most common cause of SCD [9, 10]. On the other hand, congenital heart diseases, myocarditis and hereditary arrhythmic syndromes predominate among children and young people [3, 11, 12]. If structural heart disease, channelopathy, metabolic or toxicological etiology is excluded, then a diagnosis of idiopathic ventricular fibrillation (VF) is made.

Historically, ventricular tachycardia (VT) of variable duration followed by ventricular fibrillation as the dominant malignant rhythm responsible for cardiac arrest, was reported in most cases of SCD [13]. Only a minority of SCD victims had bradycardias or asystole [14]. However, more recent studies have shown shockable rhythm only in a minority of SCD victims [15, 16, 17].

2. Mechanisms of Ventricular Fibrillation

On an electrocardiogram (ECG), VF manifests as a disorganized and chaotic electric activity of the heart ventricles. The exact underlying mechanism of VF is not entirely clear. The widely accepted hypothesis declares four phases of VF (Table 1, Ref. [18]): initiation, transition, maintenance and evolution [19]. The initiation phase of VF typically starts by premature ventricular contractions (PVCs) or the degeneration of ventricular tachycardia. Rarely does VF start without PVC as the initial factor. The timing of PVCs falls into a vulnerable period resulting in R-on-T phenomena due to the short coupling interval. The origins of VF-related PVCs may be in any part of the heart ventricles. In the absence of structural heart disease, the majority of these PVCs arise from the right ventricle outflow tract (RVOT) [20], Purkinje system [21], papillary muscles [22, 23] and ventricular myocardium [24]. A recent theory proposes that four essential components are required to initiate re-entry: a local variation in excitability (for instance, steep gradients in repolarization time), a critical balance in the size between excitable and non-excitable regions, a trigger that emerges when some tissue is excitable while other tissue is not (such as an early premature complex), and the occurrence of this trigger from an excitable area (like a region with early repolarization) [25]. At the beginning, the PVC is a local phenomenon that may terminate spontaneously or degenerate into generalized VF. In the transition phase, PVCs generate wavefronts that propagate through a heterogeneous substrate and generate a wavebreak, multiple wavelets and slow conduction. In some cases, a functional re-entry is formed [26]. The VF re-entry circuits are not typical leading-edge loops but can be specific electrophysiological entities such as spiral waves and rotors. An inert core is localized in the centre and the activation propagates as a rotational wave. The evolution of the rotor with complex disorganized wavelets is the main point of the transition phase. Two mechanisms were proposed for VF maintenance. First, multiple unstable wavelets create a self-sustaining spiral wave re-entry. Another hypothesis suggests one “mother rotor” that is responsible for promoting new wavebreaks and driver formation [27]. However, both mechanisms can coexist and overlap each other [28, 29, 30]. Finally, rotors may establish at the scar borders, where anatomical or functional abnormalities are present.

Table 1. Phases of VF with contribution factors.

Phase	Initiation	Transition	Maintenance	Evolution	
Contributing factors	∙ PVCs	∙ Alternans	∙ Focal sources	∙ Anchoring rotor to the scar	
		- RVOT	∙ Wavebreaks	∙ Motor rotor	∙ Electrical remodelling	
		- Purkinje	∙ APD heterogeneity	∙ Figure “eight” re-entry		
		- Papillary muscle	∙ Steep APD restitution			
	∙ VT	∙ CV restitution			
VF, ventricular fibrillation; PVCs, premature ventricular complexes; RVOT, right ventricle outflow tract; VT, ventricular tachycardia; APD, action potential duration; CV, conduction velocity.

Modified from Anderson et al. [18].

3. Baseline Evaluation

The standard algorithm list for evaluating SCD survivors is presented in Table 2. This chain of examinations should be performed in every case of SCD.

Table 2. Standard algorithm of examination in the case of SCD.

Personal and family history	
Physical examination	
Blood tests, toxicology screening	
Resting 12-lead ECG with right high leads	
Coronary angiogram (CT coronary angiography in children and young adults)	
Echocardiography	
Cardiac magnetic resonance	
Electrophysiology study	
Exercise stress test	
Pharmacological provocation test	
Long-term ECG monitoring	
Phenotype-guided genetic testing	
SCD, sudden cardiac death; ECG, electrocardiogram; CT, computer tomography.

The clinical examination is standardized: blood tests, toxicology screening, 12-lead surface ECG, echocardiography and coronary angiography should be performed immediately. These examinations are usually sufficient to determine the etiology of the cardiac arrest. In some cases, however, it is necessary to search further. A post-VF patient without structural heart disease is indicated for an exercise stress test, pharmacological provocation test with sodium-channel blockers, long-term ECG monitoring and cardiac magnetic resonance (CMR). The diagnosis of idiopathic ventricular fibrillation (IVF) is a diagnosis per exclusionem, so only after all examinations mentioned above are performed can IVF be considered.

Real world data show that this diagnostic algorithm has been completed in only a limited number of IVF cases. Conte et al. [31] reported the registry of IVF survivors with a normal baseline 12-lead ECG where a complete workup (coronary angiography, CMR and sodium-channel blocker challenge) was performed in 46% of the patients, and an exercise stress test was performed in 80% of the group. Other authors have also published real world data of examinations of IVF survivors (Table 3, Ref. [31, 32, 33, 34, 35, 36, 37, 38, 39, 40]). The most recent and largest study published by Groeneveld et al. [32] shows similar numbers of examinations rates. These studies show the variability of the approach to patients after cardiac arrest and prove that a chain of evaluation has not been established world-wide.

Table 3. Baseline evaluation in world-wide cohorts of IVF patients.

Author	Numbers of patients	Cardiac coronary angiogram	Cardiac magnetic resonance	Exercise test	Sodium-channel blocker challenge	
Krahn et al. (2009) [33]	63	100%	100%	100%	100%	
Visser et al. (2016) [34]	107	100%	45%	100%	58%	
Leinonen et al. (2018) [35]	76	NR	62%	75%	NR	
Waldmann et al. (2018) [36]	49	100%	82%	8%	43%	
Giudicessi et al. (2018) [37]	67	86%	73%	88%	27%	
Conte et al. (2019) [31]	245	100%	65%	80%	64%	
Frontera et al. (2019) [38]	54	44%	70%	83%	69%	
Cunningham et al. (2020) [39]	46	11%	57%	41%	NR	
Merghani et al. (2021) [40]	31	100%	77%	23%	81%	
Groeneveld et al. (2023) [32]	423	96%	75%	70%	63%	
NR, not reported; IVF, idiopathic ventricular fibrillation.

3.1 Personal and Family History

Anamnesis is the cornerstone of any diagnostic process. A detailed personal and clinical history from the patient him/herself and from family members is essential to provide insight into the potential etiology of SCD. A history of chest pain increases the probability of ischemic heart disease. Fever, hypothermia, dehydration can trigger life-threatening arrhythmia in genetic heart disease. For example, fever has been associated with malignant arrhythmias in 6% of patients with cardiac arrest and Brugada syndrome (BrS) [41]. An anamnesis of PVCs is associated with a higher risk of ventricular fibrillation [42]. Moreover, information that at first glance seems unimportant can be valuable. For example, an unexplained car accident in the past can be a sign of arrhythmic syncope. A family history of unexplained death, especially in young family members, is always a red flag and may provide an important clue to considering hereditary arrhythmic syndrome. Any banal unexplained accident with short unconsciousness by a family member should also be thoroughly investigated.

Medical history is very important clue too. Various drugs (also non-cardiological) may be proarrhythmic especially when used in combination. Many drugs are well-known for their potential for QT interval prolongation or provocation of a Brugada type 1 ECG pattern. There are websites with databases of potentially or definitive QT prolonging (http://www.QTdrugs.org/) or Brugada pattern provocation drugs (https://www.brugadadrugs.org/).

3.2 Physical Examination

Physical examination is the first step. This non-invasive examination can provide essential information and guide us to identify signs of syndromic and non-syndromic diseases that can be associated with SCD. Obesity and xanthomata may indicate coronary artery disease, while muscle weakness and atrophy may signalize lamin or desmin cardiomyopathies. Other physical signs include cardiac murmur in valve diseases, foetor ex ore in diabetic coma, and typical alcoholic or chemical foetor in an intoxicated patient. Body temperature must be measured repeatedly, and fever with rigor and shivering are signs of infection and can be a starter of VF associated with hereditary arrhythmic syndromes.

3.3 Blood Tests

Besides physical examination, paraclinical methods are also important for differential diagnostics. Standard blood tests targeted for levels of electrolytes, renal and liver function, high-sensitive troponin and other cardiac markers, and differential blood count are included in the standard protocol. Hypokalemia is prevalent in out-of-hospital cardiac arrest survivors due to the prolongation of the QT interval duration which canstart ventricular tachycardia [43, 44]. In any SCD survivor case, drug testing is required. Drug abuse is clearly associated with higher risk of arrhythmias, including VF [45, 46, 47]. In the absence of this information, the laboratory tests can be considered incomplete.

3.4. Resting Electrocardiography

A standard 12-lead ECG in patients after SCD may show various types of conduction abnormalities with dynamic changes in a short time, although a completely normal ECG curve is not rare. A detailed examination of a resting ECG with high right leads is recommended. PVCs may be present hours and days after ventricular fibrillation and resuscitation, the significance of which is commonly underestimated. Recording these PVCs on a 12-lead ECG is crucial for identifying the place of origin (left or right ventricle, outflow tract or Purkinje system). Non-RVOT or left ventricular PVCs are diagnostic criteria for arrhythmogenic cardiomyopathy (ACM) [48]. The PVC morphology may also be important for an ablation procedure in the future. Purkinje ectopias have a narrower QRS duration, especially from the left Purkinje system (duration QRS <120 ms) and a right bundle branch block morphology. A wider QRS duration (130–150 ms) with a left bundle branch block pattern is typical for Purkinje ectopias from the right Purkinje system.

An early repolarization ECG pattern (ERP) with typical J-point elevation on a 12-lead ECG is a common finding on ECG in the general population. In the ventricular arrhythmia-free population, the prevalence of ERP is generally reported from 5% [24] to 8.1% [49] and is more likely in young men and athletes [50, 51]. Early repolarization syndrome (ERS) is a different clinical entity [50, 52]. Haïssaguerre et al. [24] found ERS in up to 31% of IVF cases, compared to 5% in the control group. Mellor et al. [53] reported a significantly higher prevalence of ERP in SCD survivor relatives compared to the general population. In the absence of other clinical abnormalities, risk stratification and population screening are difficult to perform in patients with an ER pattern on resting ECG. High-risk ECG features have been proposed to increase the likelihood of ERS: prominent J-waves ≥2 mm, dynamic changes in J-point elevation (≥0.1 mV) and J-waves associated with a horizontal or descending ST-segment [50, 54, 55].

A specific group of IVF patients are individuals with VF induced by short-coupled PVCs. Generally, this group has not been excluded from IVF. It has been suggested as a new diagnostic entity—short-coupled VF (SCVF)—where the inducing factor of VF is a short-coupled PVC with a coupling interval <350 ms [56]. Steinberg et al. [57] retrospectively evaluated a cohort of patients in the CASPER registry to assess the proportion of SCVF. They reported a prevalence of 6.6% in the registry. Groeneveld et al. [58] in the Dutch IVF registry diagnosed SCVF in 14% of cases.

QT Interval Measurement

Correctly measuring the QT duration is extremely important. A study from Viskin et al. [59] showed that most physicians cannot find QT prolongation on pathological ECG. Like all ECG parameters, the QT interval also looks different in different leads. Historically, the QT interval was measured in lead II and the reference values are also determined for this lead [60]. In most children with long QT syndrome (LQTs), the longest QT interval was found in lead II as well [61]. In the situation where it is hard to recognize the start and end of the QT interval, lead I or V5 or V6 can be used, but the U-wave in the measurement of the QT interval must be avoided. A standard 12-lead ECG tracing at a paper speed of 25 mm/s and amplitude at 10 mm/mV is generally adequate for accurately measuring the QT interval duration in a healthy person, but for an accurate diagnostic algorithm, higher ECG paper speeds of 50 mm/sec may be used for identifying the low-amplitude waves such as U-waves. The QT interval should be determined as a mean value derived from at least 3–5 cardiac cycles and is measured from the beginning of the earliest onset of the QRS complex to the end of the T-wave [62]. In common practice, two measurement methods can be used - the threshold method and the tangential method. Currently, neither method is preferred. However, differences in the value of the measured QT interval are present [63]. The tangential method of measuring the QT [64] can be used for a difficult ECG, where the end of the T-wave is challenging to find, or the T- and U-waves are inseparable.

QT interval correction for heart rate is a disputable problem as old as ECG itself. Historically, in 1920 the two most commonly used correction formulas from Bazett [65] and Fridericia [66] were published. Because both formulas are logarithmic corrections, however, they are not accurate for slower heart rates under 60/min. Fridericia’s formula is considered to be more accurate than Bazett’s correction at faster heart rates above 100/min. These limits of both correction formulas must be mentioned in the cases of tachycardia or bradycardia.

In 2010, Viskin et al. [67] reported a simple test to detect corrected QT interval (QTc) prolongation in sinus tachycardia induced by orthostasis. In this study, the authors declared QTc prolongation after brisk standing in patients with LQTs compared to a control group. However, recent re-evaluation by Vink et al. [68] shows inconsistent findings. In light of these findings, the standing test is not superior to the standard ECG and exercise test for the diagnosis of LQTs. On the other hand, the standing test could be helpful for experts to stratify future arrhythmic risk.

Short QT syndrome (SQTs) is a rare condition characterized by short QT duration and premature atrial and ventricular fibrillation in the absence of structural heart disease [69]. According to current guidelines, SQTs are diagnosed in the presence of QT duration <320 ms alone or <360 ms and a history of aborted SCD or family history of SQTs or pathologic genetic findings (in genes KCNH2, KCNQ1 and SLC4A) [2].

3.5 Cardiac Imaging Methods

3.5.1 Coronary Angiography

In all SCD survivors, the anatomy of their coronary arteries must be well known to exclude coronary artery disease or congenital abnormalities. In the absence of pathological ST segment changes on the initial ECG, it is not necessary to perform emergency angiography. In young patients, computer tomography (CT) coronary angiography may be considered prior to invasive catheter coronary angiography.

3.5.2 Echocardiography

Echocardiographic examination is a first-line method to detect structural abnormalities of the heart. This low-cost, rapid, and radiation-free imaging method serves to visualize the heart wall motion and thickness, ejection fraction and valvular disease. However, it cannot be used to diagnose myocardial inflammation and local distribution of fibrosis.

With the development of the speckle tracking method, a subgroup of IVF patients with abnormal local and global deformation of the ventricles can be identified. Compared with healthy controls, IVF survivors showed more global deformation abnormalities as indicated by lower left ventricle (LV) global longitudinal strain and higher LV mechanical dispersion. Similarly, abnormal right ventricle deformation patterns have also been observed [70].

3.5.3 Cardiac Magnetic Resonance

The development and increased availability of CMR in recent decades have provided us with an additional important tool for the diagnostic evaluation of SCD survivors. CMR findings can lead to a definitive diagnosis in cases of a normal echocardiogram [71]. In a study of 137 post-SCD patients, Neilan et al. [72] diagnosed or identified an arrhythmic substrate in up to 76% of all individuals after CMR was performed. Using T2 weighted sequences, specialists detected myocardial edema and fibrosis using late gadolinium enhancement. CMR enables the detection of myocardial inflammation, and confirmation of myocarditis completely changes the treatment and prognosis of the patient. There are, however, some genetic diseases which can mimic myocarditis. Desmoplakin cardiomyopathy can manifest as acute myocardial injury with a typical picture of inflammation on CMR. In this case, a genetic examination can provide the key to diagnosis [73]. To accurately measure right ventricle size and function, the role of CMR is crucial for diagnosing ACM, which is not only arrhythmic right ventricular cardiomyopathy (ARVC), as arrhythmogenic substrate can be expressed in the left ventricle or also in both ventricles. A group of authors from the Medical School of the University of Padua designed the Padua criteria for diagnosing ACM of the left ventricle by structural and functional abnormalities [48].

A relatively new entity in a subgroup of SCD survivors is mitral valve prolapse (MVP) and mitral valve disjunction (MVD). The incidence of MVP in an unselected population of SCD is generally documented below 1% [74, 75] but is reported from 4% [76] up to 11% in a subgroup of young patients with SCD [77, 78]. MVP is defined as a systolic displacement of one or both mitral leaflets ≥2 mm above the plane of the mitral annulus in the sagittal view of the mitral valve [79, 80, 81]. MVD is characterized by a systolic separation between the ventricular myocardium and the mitral annulus supporting the posterior mitral leaflet [82]. A patient with MVP/MVD may develop a wide variety of arrhythmias, from benign supraventricular premature beats to life-threatening ventricular arrhythmias and SCD. Mitral annulus disjunction and mitral valve prolapse are frequently overlooked and deserve extra attention in the extensive screening of patients with idiopathic ventricular fibrillation.

3.5.4 Scintigraphy

The state of sympathetic innervation of the left and right ventricles can provide us with important information in the case of a high suspicion of ARVC and inconclusive CMR. Todica et al. [83] published a study with 123Iodine-Metaiodobenzylguanidine (123I-MIBG) single-photon emission computed tomography (SPECT)/CT to determine the quantity of right ventricle sympathetic innervation, which is lower in the case of ARVC compared to IVF. Another study by Siebermair et al. [84] demonstrated that impaired myocardial sympathetic innervation assessed by (123I-MIBG) SPECT is associated with cardiac events in a group of IVF patients.

3.6 Electrophysiology Study

Thanks to the development of better technology and research, the role of the electrophysiology study (EPS) in IVF cases is growing. While supraventricular tachycardias (SVT) are commonly benign, Wang et al. [85] reported a group of patients with SVT that deteriorated into VF. Other evidence of SCD caused by Wolf-Parkinson-White syndrome and other SVT has also been found [86]. The findings of these cases in a group of IVF patients are helping to rapidly change their prognosis. Another subgroup of patients with IVF shows PVCs triggering VF or localized structural alternations during EPS [87]. By modifying the triggering substrate VF events may be reduced and patients’ quality of life improved.

3.7 Exercise Stress Test

An exercise stress test should be a routine test in SCD survivors as it is safe, cheap, and widely available. In IVF cases this test is aimed at exercise-induced ventricular arrhythmias and assessment of the QT interval and T-wave morphology.

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is still an underdiagnosed cause of cardiac arrest, especially in young individuals. While in resting conditions the ECG has no abnormalities, with increasing adrenergic stimulation polymorphic PVCs can occur. Bidirectional PVCs and/or polymorphic ventricular tachycardias are typical for a diagnosis of CPVT, and these arrhythmias can even degenerate into ventricular fibrillation. Data from studies confirm the importance of exercise stress testing [88]. Roston et al. [89] reported better results with a modified exercise test protocol with a sudden high workload at the beginning of testing to evaluate CPVT in a non-diagnostic standard protocol. Establishing the correct diagnosis has a great impact on further treatment, lifestyle recommendations and screening in the patient’s family.

An exercise stress test is highly valuable for detecting LQTs. Although QT interval prolongation on the baseline ECG is highly specific for LQTs, the QT interval often changes rapidly and may even be normal [90]. For a better diagnosis of LQTs, an exercise stress test is recommended [2]. It serves as an ideal method for physiologically altering autonomic tone, with good sensitivity and specificity for diagnostic LQTs [91]. Schwartz and Crotti [92] published a scoring system to establish the probability of LQTs. We currently use a modified Schwartz score (Table 4, Ref. [2]), where one part of the score represents exercise testing with QT interval prolongation of more than 480 ms at the 4th minute of recovery [2]. A score of more than 3 points means a definitive diagnosis of LQTs.

Table 4. Modified LQTs scoring system.

Findings	Points	
ECG	QTc	≥480 ms	3.5	
460 ms–479 ms	2	
450 ms–459 ms	1	
≥ 480 ms in 4th minute of recovery from exercise stress test	1	
Torsades de pointes		2	
T-wave alternans		1	
Notched T-wave in 3 leads		1	
Low hearth rate for age		0.5	
Clinical history	Syncope with stress		2	
Syncope without stress		1	
Family history	Family member with definitive LQTs		1	
Unexplained SCD in first degree family member at age <30		0.5	
Genetic testing	Definitive pathogenic mutation		3.5	
ECG, electrocardiogram; QTc, corrected QT interval; LQTs, long QT syndrome; SCD, sudden cardiac death.

Modified from 2022 ESC Guidelines [2].

3.8 Pharmacological Provocation Tests

BrS is diagnosed in patients without structural heart disease and a documented spontaneous Brugada type-1 ECG pattern or a history of syncope or SCD with a positive pharmacological provocation test [50, 93]. Brugada pattern ECG after the infusion of a sodium channel blocker does not automatically mean a diagnosis of BrS without other symptoms such as syncope or polymorphic ventricular tachycardia. This is a major change compared to the 2015 ESC Guidelines [1, 2] and leads us to be more specific with a diagnosis of BrS. The standard provocation test to uncover BrS is sodium channel blocker infusion with continuous 12-lead ECG monitoring modified with high right leads. Only a Brugada type-1 ECG should be considered as a positive result. Provocation tests are underused in clinical praxis. Conte et al. [31] reported that only 64% of patients underwent an ajmaline test. A repeated ajmaline challenge test may be considered to better detect BrS, especially in adults [94].

Coronary vasospasm is a rare cause of ventricular fibrillation. A provocation pharmacological test with ergonovine or acetylcholine can be used if coronary vasospasm is highly suspected as the etiology of SCD [95].

3.9 Prolonged ECG Monitoring

After an episode of SCD that is presented with VF, long-term ECG monitoring is also indicated. In general, men with frequent PVCs have an increased risk of SCD compared to controls. We look for PVCs, heart rate variability, bradycardias, ST segment changes and QT duration [96]. The duration of the QT interval may change according to physical activity, resting and emotional state, and variates in time. Long-term ECG recording may be more effective in monitoring the QT interval duration. Exercise-induced PVCs and ventricular tachycardia that do not manifest during a stress test in a medical centre may be presented during ambulatory ECG monitoring. Sitorus et al. [97] reported up to 33% recurrence of ventricular arrhythmias in individuals after SCD.

3.10 Genetic Background

For decades it has been well known that the occurrence of SCD has strong familial aggregation in the general population [98, 99]. Dekker et al. [100] showed that patients with a family history of SCD have a higher risk of VF during acute myocardial infarction (MI) compared to patients without a family history of SCD and acute myocardial infarction. All of these studies suggest a strong genetic component in SCD pathophysiology. Yet the precise mechanisms remain unclear. At the beginning of the “genetic era”, most clinicians expected simple answers, but with more and more information comes more and more questions. To date, many candidate genes have been reported for each inherited arrhythmic disease. Thus, genetic screening should have a high potential to identify individuals at risk for SCD. Nevertheless, a recent genome-wide association study (GWAS) exploring the genomics of SCD (the most extensive study of this type so far) failed to replicate an association of previously identified common genetic variants with SCD. Recently, the Clinical Genome Resource Consortium of the National Institute of Health has provided evidence-based curations of the clinical relevance of genes and gene-disease validity. Only genes with a classification of definitive or those with strong evidence supporting disease causation should be tested in patients with a clear specific phenotype [101].

Genetic Testing in IVF

According to current guidelines, IVF genetic testing related to channelopathy and cardiomyopathy may be considered with a mutation yield of 3–17% [2]. Most often, pathogenic variants related to LQTs, CPVT and BrS are identified [102, 103]. Interestingly, pathogenic variants in cardiomyopathy-related genes are also being found in a small proportion of idiopathic VF individuals despite the clinical exclusion of any structural abnormalities in these cases. This finding may suggest a latent structural underlying substrate and clinical phenotype could evolve later [104]. Nowadays, most IVF patients undergo genetic testing. However, the general detection of pathological gene variants is low. Verheul et al. [105] reviewed genetic results from a Dutch IVF registry. They reported findings of likely pathogenic/pathogenic (LP/P) variants in 15% of cases, including the risk haplotype DPP6. The most frequent LP/P variant found in cardiomyopathy-related genes was in FLNC, MYL2, MYH7, PLN, TTN, and RBM20. Change in diagnosis based on genetic testing results was present in 2% of cases. However, most gene variants were variants of uncertain significance (VUS) (30% of all results). This demonstrates the great uncertainty in the interpretation of genetic testing results in IVF patients. In common clinical practice, it is very difficult to establish a causal relationship between the IVF phenotype and the genetic findings of VUS.

LQTs is a condition with a prevalence of 1:2500 [106], which is borderline for rare diseases. In 2020, Adler et al. [107] revised all 17 genes previously associated with LQTs. Only the 3 oldest genes (KCNQ1, KCNH2 and SCN5A) have been identified for phenotypically isolated LQTs causality. Another 4 genes (CALM1, CALM2, CALM3, TRDN) were found to have definitive evidence for causality in LQTs with atypical features. A list of LQTs-associated genes can be found in Table 5. Following this study, other genes are not recommended for genetic testing [101].

Table 5. Genes associated with LQTs.

Gene	Phenotype	ClinGen classification	
KCNQ1	LQTs, JLNs	Definitive	
KCNH2	LQTs	Definitive	
SCN5A	LQTs	Definitive	
CALM1	LQTs	Definitive	
CALM2	LQTs	Definitive	
CALM3	LQTs	Definitive	
CACNA1C	Ts	Definitive in Ts	
KCNE1	LQTs, JLNs, a-LQTs	Definitive in JLNs, Strong in a-LQTs	
KCNJ2	ATs	Definitive in ATs	
TRDN	Recessive LQTs	Strong	
KCNE2	a-LQTs	Strong	
LQTs, long QT syndrome; JLNs, Jervell Lange-Nielsen syndrome; ATs, Andersen-Tawil syndrome; a-LQTS, acquired long QT syndrome; Ts, Timothy syndrome.

The most common CPVT-causative gene is RYR2 [108, 109] with sporadic de novo variants. Other genes associated with the CPVT phenotype are CALM 1-3 [110], CASQ2, TRDN and TECRL [111, 112, 113, 114, 115] (Table 6). Similar to the LQTs’ “Schwartz score”, Giudicessi et al. [116] developed a clinical scoring system (without a genetic test result) for patients with a CPVT phenotype; for details see Table 7 (Ref. [116]).

Table 6. Genes associated with CPVT.

Gene	Phenotype	ClinGen classification	
RyR2	CPVT – AD	Definitive	
TECRL	CPVT – AR	Definitive	
TRDN	CPVT – AR	Definitive	
CALM 1-3	CPVT – AD	Strong	
CASQ2	CPVT – AR	Strong	
CASQ2	CPVT – AD	Moderate	
CPVT, catecholaminergic polymorphic ventricular tachycardia; AD, autosomal dominant; AR, autosomal recessive.

Table 7. Giudicessi scoring system for CPVT.

Criteria	Points	
Symptoms		
	Exercise-related SCD	2	
	Exercise-related syncope or generalized seizures	1	
Exercise stress test		
	Bi-directional ventricular tachycardia ≥100/min	4	
	PVCs in bigeminy and bidirectional couples at HR ≥100/min	2	
	PVCs at HR ≥100/min	1	
Baseline QTc		
	≤420 ms	0.5	
	421 ms–460 ms	0	
	≥460 ms	–0.5	
Genetic testing		
	Definitive pathogenic variant	4	
	Likely pathogenic variant	2	
	Variant of uncertain significance	0	
	Negative findings	–1	
ECG Holter examination		
	PVCs ≥2%	–1	
Cardiac imaging		
	Structural or ischemic disease	–2	
Age		
	≥50 years	–1	
Family history		
	Definitive CVPT in first-degree relative	1.5	
	Suspicious autopsy-negative SCD in first- or second-degree relative ≤45 years	1	
	Unexplained autopsy-negative SCD in first- or second-degree relative ≤45 years	0.5	
CPVT, catecholaminergic polymorphic ventricular tachycardia; SCD, sudden cardiac death; PVCs, premature ventricle complexes; HR, heart rate; QTc, corrected QT interval; ECG, electrocardiogram.

Modified from Giudicessi et al. [116].

Concerning BrS, currently only the SCN5A gene (Table 8) has a definitive disease association. Approximately 20% of BrS cases are carriers of the SCN5A pathological variant [117]. The low number of this variant in the clinical presentation of BrS indicates a polygenic etiology of the disease. Cascade genetic screening is recommended in a family with a relative with BrS and an identified pathogenic or likely pathogenic SCN5A variant [101].

Table 8. Genes associated with BrS.

Gene	Phenotype	ClinGen classification	
SCN5A	BrS	Definitive	
BrS, Brugada syndrome.

3.11 Long-Term Follow-up

Even after the complete diagnostic algorithm and implantable cardioverter-defibrillator (ICD) implantation, it is advisable to periodically review the IVF diagnosis. Regular recording of ECG at each follow-up visit may reveal a latent form of inherited syndromes. When a phenotype of hereditary syndromes is suspected, also periodic stress testing should be considered. As shown by Merghani et al. [40] regular re-evaluation can increase the specific diagnosis from an initial 31% to 64%. Also, analysis of Dutch registry data shows a 9% increase in definitive diagnosis during follow-up [32]. Visser et al. [34] even report an increase in the number of definitive diagnoses during follow-up to 21%.

The specific diagnosis is also related to the prognosis of the patient. Survivors of sudden cardiac arrest (SCA) due to IVF have a high recurrence rate of arrhythmic events [31]. As shown in the Dutch registry analysis, patients with an alternative diagnosis have a higher chance of shocks compared to IVF patients. A correct diagnosis will therefore help to improve patient care with tailored treatment. However, Herman et al. [118] reported no significant difference in the number of ICD therapies between patients with IVF and alternative diagnoses in the CASPER registry.

4. Conclusions

IVF is still not very well understood, and the recommended diagnostic algorithm is often not systematically used. It seems that a significant portion of IVF in patients is only attributed to undiagnosed inherited electric syndromes. While modern advanced imaging methods can help us reveal more specific structural abnormalities, further research is needed in the field of echocardiography after IVF. Identifying the underlying etiology is essential for proper treatment and patient prognosis. With a correct diagnosis, we have the opportunity to reduce the recurrence of arrhythmias and to find family members at risk through family cascade screening. In the future, genome sequencing of true IVF survivors and their families, as well as computer models of cardiomyocytes, may shed more light on understanding the principles and substrate of IVF, which can lead to better healthcare for these patients. The result of this review should be an appeal for all clinicians to follow the described comprehensive algorithm for the examination of patients after SCD. It can be said that ICD implantation is not the end of the journey, but only the beginning.

Acknowledgment

Special thanks to Beau Daquila for language editing and proofreading of the manuscript.

Abbreviations

ACM, arrhythmogenic cardiomyopathy; ARVC, arrhythmic right ventricular cardiomyopathy; BrS, Brugada syndrome; CMR, cardiac magnetic resonance; CPVT, catecholaminergic polymorphic ventricular tachycardia; ECG, electrocardiogram; EPS, electrophysiology study; ERP, early repolarization pattern; ERS, early repolarization syndrome; ICD, implantable cardioverter-defibrillator; IVF, idiopathic ventricular fibrillation; LP/P, likely pathogenic/pathogenic; LQTs, long QT syndrome; LV, left ventricle; MVD, mitral valve disjunction; MVP, mitral valve prolaps; PVCs, premature ventricular contractions; RVOT, right ventricle outflow tract; SCD, sudden cardiac death; SCVF, short-coupled ventricular fibrillation; SQTs, short QT syndrome; SVT, supraventricular tachycardia; VF, ventricular fibrillation; VT, ventricular tachycardia; VUS, variants of uncertain significance.

Author Contributions

SL, MS and TN made substantial contributions to conception and design of the study. SL, MS and TN performed literature searching and review. All authors participated in writing or revising the manuscript. All authors read and approved the final version of the manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.

Ethics Approval and Consent to Participate

Not applicable.

Funding

Supported by the Ministry of Health of the Czech Republic – Grant NU22-02-00348 and by MH CZ - DRO (FNBr, 65269705).

Conflict of Interest

The authors declare no conflict of interest.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

[1] Priori SG Blomström-Lundqvist C Mazzanti A Blom N Borggrefe M Camm J et al 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal 2015 36 2793 2867 26320108
[2] Zeppenfeld K Tfelt-Hansen J de Riva M Winkel BG Behr ER Blom NA et al 2022 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death European Heart Journal 2022 43 3997 4126 36017572
[3] Winkel BG Holst AG Theilade J Kristensen IB Thomsen JL Ottesen GL et al Nationwide study of sudden cardiac death in persons aged 1-35 years European Heart Journal 2011 32 983 990 21131293
[4] Pilmer CM Kirsh JA Hildebrandt D Krahn AD Gow RM Sudden cardiac death in children and adolescents between 1 and 19 years of age Heart Rhythm 2014 11 239 245 24239636
[5] Risgaard B Winkel BG Jabbari R Behr ER Ingemann-Hansen O Thomsen JL et al Burden of sudden cardiac death in persons aged 1 to 49 years: nationwide study in Denmark Circulation. Arrhythmia and Electrophysiology 2014 7 205 211 24604905
[6] Fishman GI Chugh SS Dimarco JP Albert CM Anderson ME Bonow RO et al Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop Circulation 2010 122 2335 2348 21147730
[7] Wong CX Brown A Lau DH Chugh SS Albert CM Kalman JM et al Epidemiology of Sudden Cardiac Death: Global and Regional Perspectives Heart, Lung & Circulation 2019 28 6 14
[8] Bougouin W Lamhaut L Marijon E Jost D Dumas F Deye N et al Characteristics and prognosis of sudden cardiac death in Greater Paris: population-based approach from the Paris Sudden Death Expertise Center (Paris-SDEC) Intensive Care Medicine 2014 40 846 854 24658912
[9] Waldmann V Karam N Bougouin W Sharifzadehgan A Dumas F Narayanan K et al Burden of Coronary Artery Disease as a Cause of Sudden Cardiac Arrest in the Young Journal of the American College of Cardiology 2019 73 2118 2120 31023437
[10] Waldmann V Karam N Rischard J Bougouin W Sharifzadehgan A Dumas F et al Low rates of immediate coronary angiography among young adults resuscitated from sudden cardiac arrest Resuscitation 2020 147 34 42 31857140
[11] Bagnall RD Weintraub RG Ingles J Duflou J Yeates L Lam L et al A Prospective Study of Sudden Cardiac Death among Children and Young Adults The New England Journal of Medicine 2016 374 2441 2452 27332903
[12] Winkel BG Risgaard B Sadjadieh G Bundgaard H Haunsø S Tfelt-Hansen J Sudden cardiac death in children (1-18 years): symptoms and causes of death in a nationwide setting European Heart Journal 2014 35 868 875 24344190
[13] Holmberg M Holmberg S Herlitz J Incidence, duration and survival of ventricular fibrillation in out-of-hospital cardiac arrest patients in sweden Resuscitation 2000 44 7 17 10699695
[14] Priori SG Aliot E Blomstrom-Lundqvist C Bossaert L Breithardt G Brugada P et al Task Force on Sudden Cardiac Death of the European Society of Cardiology European Heart Journal 2001 22 1374 1450 11482917
[15] Kurz MC Schmicker RH Leroux B Nichol G Aufderheide TP Cheskes S et al Advanced vs. Basic Life Support in the Treatment of Out-of-Hospital Cardiopulmonary Arrest in the Resuscitation Outcomes Consortium Resuscitation 2018 128 132 137 29723609
[16] Patil KD Halperin HR Becker LB Cardiac arrest: resuscitation and reperfusion Circulation Research 2015 116 2041 2049 26044255
[17] Oving I de Graaf C Karlsson L Jonsson M Kramer-Johansen J Berglund E et al Occurrence of shockable rhythm in out-of-hospital cardiac arrest over time: A report from the COSTA group Resuscitation 2020 151 67 74 32278017
[18] Anderson RD Kumar S Kalman JM Sanders P Sacher F Hocini M et al Catheter Ablation of Ventricular Fibrillation Heart, Lung & Circulation 2019 28 110 122
[19] Cheniti G Hocini M Martin R Sacher F Dubois R Haissaguerre M et al Is VF an Ablatable Rhythm? Current Treatment Options in Cardiovascular Medicine 2017 19 14 28285456
[20] Haïssaguerre M Shoda M Jaïs P Nogami A Shah DC Kautzner J et al Mapping and ablation of idiopathic ventricular fibrillation Circulation 2002 106 962 967 12186801
[21] Haïssaguerre M Shah DC Jaïs P Shoda M Kautzner J Arentz T et al Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation Lancet (London, England) 2002 359 677 678 11879868
[22] Van Herendael H Zado ES Haqqani H Tschabrunn CM Callans DJ Frankel DS et al Catheter ablation of ventricular fibrillation: importance of left ventricular outflow tract and papillary muscle triggers Heart Rhythm 2014 11 566 573 24398086
[23] Santoro F Di Biase L Hranitzky P Sanchez JE Santangeli P Perini AP et al Ventricular fibrillation triggered by PVCs from papillary muscles: clinical features and ablation Journal of Cardiovascular Electrophysiology 2014 25 1158 1164 24946987
[24] Haïssaguerre M Derval N Sacher F Jesel L Deisenhofer I de Roy L et al Sudden cardiac arrest associated with early repolarization The New England Journal of Medicine 2008 358 2016 2023 18463377
[25] Cluitmans MJM Bayer J Bear LR Ter Bekke RMA Heijman J Coronel R et al The circle of reentry: Characteristics of trigger-substrate interaction leading to sudden cardiac arrest Frontiers in Cardiovascular Medicine 2023 10 1121517 37139119
[26] Weiss JN Qu Z Chen PS Lin SF Karagueuzian HS Hayashi H et al The dynamics of cardiac fibrillation Circulation 2005 112 1232 1240 16116073
[27] Chen J Mandapati R Berenfeld O Skanes AC Jalife J High-frequency periodic sources underlie ventricular fibrillation in the isolated rabbit heart Circulation Research 2000 86 86 93 10625309
[28] Jalife J Ventricular fibrillation: mechanisms of initiation and maintenance Annual Review of Physiology 2000 62 25 50
[29] Nash MP Mourad A Clayton RH Sutton PM Bradley CP Hayward M et al Evidence for multiple mechanisms in human ventricular fibrillation Circulation 2006 114 536 542 16880326
[30] Pandit SV Jalife J Rotors and the dynamics of cardiac fibrillation Circulation Research 2013 112 849 862 23449547
[31] Conte G Belhassen B Lambiase P Ciconte G de Asmundis C Arbelo E et al Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: results from a multicentre long-term registry Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology 2019 21 1670 1677 31504477
[32] Groeneveld SA Verheul LM van der Ree MH Mulder BA Scholten MF Alings M et al Importance of Systematic Diagnostic Testing in Idiopathic Ventricular Fibrillation: Results from the Dutch iVF Registry JACC. Clinical Electrophysiology 2023 9 345 355 36752476
[33] Krahn AD Healey JS Chauhan V Birnie DH Simpson CS Champagne J et al Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER) Circulation 2009 120 278 285 19597050
[34] Visser M van der Heijden JF van der Smagt JJ Doevendans PA Wilde AA Loh P et al Long-Term Outcome of Patients Initially Diagnosed with Idiopathic Ventricular Fibrillation: A Descriptive Study Circulation. Arrhythmia and Electrophysiology 2016 9 e004258 27733492
[35] Leinonen JT Crotti L Djupsjöbacka A Castelletti S Junna N Ghidoni A et al The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia? International Journal of Cardiology 2018 250 139 145 29032884
[36] Waldmann V Bougouin W Karam N Dumas F Sharifzadehgan A Gandjbakhch E et al Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation European Heart Journal 2018 39 1981 1987 29566157
[37] Giudicessi JR Ackerman MJ Role of genetic heart disease in sentinel sudden cardiac arrest survivors across the age spectrum International Journal of Cardiology 2018 270 214 220 29884292
[38] Frontera A Vlachos K Kitamura T Mahida S Pillois X Fahy G et al Long-Term Follow-Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications Journal of the American Heart Association 2019 8 e011172 31057083
[39] Cunningham T Roston TM Franciosi S Liu MC Atallah J Escudero CA et al Initially unexplained cardiac arrest in children and adolescents: A national experience from the Canadian Pediatric Heart Rhythm Network Heart Rhythm 2020 17 975 981 32036023
[40] Merghani A Monkhouse C Kirkby C Savvatis K Mohiddin SA Elliott P et al Diagnostic Impact of Repeated Expert Review & Long-Term Follow-Up in Determining Etiology of Idiopathic Cardiac Arrest Journal of the American Heart Association 2021 10 e019610 34056909
[41] Michowitz Y Milman A Sarquella-Brugada G Andorin A Champagne J Postema PG et al Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada Syndrome Heart Rhythm 2018 15 1394 1401 29649615
[42] Belhassen B Tovia-Brodie O Red Flags in Syncope: Clues for the Diagnosis of Idiopathic Ventricular Fibrillation The American Journal of Medicine 2022 135 1434 1436 35878689
[43] Buylaert WA Calle PA Houbrechts HN Serum electrolyte disturbances in the post-resuscitation period The Cerebral Resuscitation Study Group. Resuscitation. 1989 17 Suppl S189 S196 discussion S199 S206
[44] Thompson RG Cobb LA Hypokalemia after resuscitation from out-of-hospital ventricular fibrillation JAMA 1982 248 2860 2863 7143648
[45] Bjune T Risgaard B Kruckow L Glinge C Ingemann-Hansen O Leth PM et al Post-mortem toxicology in young sudden cardiac death victims: a nationwide cohort study Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology 2018 20 614 621 28339816
[46] Morentin B Ballesteros J Callado LF Meana JJ Recent cocaine use is a significant risk factor for sudden cardiovascular death in 15-49-year-old subjects: a forensic case-control study Addiction (Abingdon, England) 2014 109 2071 2078 25041688
[47] Bauman JL Grawe JJ Winecoff AP Hariman RJ Cocaine-related sudden cardiac death: a hypothesis correlating basic science and clinical observations Journal of Clinical Pharmacology 1994 34 902 911 7983233
[48] Corrado D Perazzolo Marra M Zorzi A Beffagna G Cipriani A Lazzari MD et al Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria International Journal of Cardiology 2020 319 106 114 32561223
[49] Matta MG Gulayin PE García-Zamora S Gutierrez L Rubinstein AL Irazola VE et al Epidemiology of early repolarization pattern in an adult general population Acta Cardiologica 2020 75 713 723 31526309
[50] Antzelevitch C Yan GX Ackerman MJ Borggrefe M Corrado D Guo J et al J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology 2017 19 665 694 28431071
[51] Rosso R Kogan E Belhassen B Rozovski U Scheinman MM Zeltser D et al J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance Journal of the American College of Cardiology 2008 52 1231 1238 18926326
[52] Haïssaguerre M Nademanee W Hocini M Duchateau J André C Lavergne T et al The Spectrum of Idiopathic Ventricular Fibrillation and J-Wave Syndromes: Novel Mapping Insights Cardiac Electrophysiology Clinics 2019 11 699 709 31706476
[53] Mellor GJ Blom LJ Groeneveld SA Winkel BG Ensam B Bargehr J et al Familial Evaluation in Idiopathic Ventricular Fibrillation: Diagnostic Yield and Significance of J Wave Syndromes Circulation. Arrhythmia and Electrophysiology 2021 14 e009089 33550818
[54] Rosso R Glikson E Belhassen B Katz A Halkin A Steinvil A et al Distinguishing “benign” from “malignant early repolarization”: the value of the ST-segment morphology Heart Rhythm 2012 9 225 229 21914497
[55] Tikkanen JT Junttila MJ Anttonen O Aro AL Luttinen S Kerola T et al Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome Circulation 2011 123 2666 2673 21632493
[56] van der Ree MH Postema PG What’s in a name? further classification of patients with apparent idiopathic ventricular fibrillation European Heart Journal 2021 42 2839 2841 34151362
[57] Steinberg C Davies B Mellor G Tadros R Laksman ZW Roberts JD et al Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry European Heart Journal 2021 42 2827 2838 34010395
[58] Groeneveld SA van der Ree MH Mulder BA Balt J Wilde AAM Postema PG et al Prevalence of Short-Coupled Ventricular Fibrillation in a Large Cohort of Dutch Patients with Idiopathic Ventricular Fibrillation Circulation 2022 145 1437 1439 35500051
[59] Viskin S Rosovski U Sands AJ Chen E Kistler PM Kalman JM et al Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one Heart Rhythm 2005 2 569 574 15922261
[60] Moss AJ Measurement of the QT interval and the risk associated with QTc interval prolongation: a review The American Journal of Cardiology 1993 72 23B 25B
[61] Garson A Jr Dick M 2nd Fournier A Gillette PC Hamilton R Kugler JD et al The long QT syndrome in children. An international study of 287 patients Circulation 1993 87 1866 1872 8099317
[62] Goldenberg I Moss AJ Zareba W QT interval: how to measure it and what is “normal” Journal of Cardiovascular Electrophysiology 2006 17 333 336 16643414
[63] Vink AS Neumann B Lieve KVV Sinner MF Hofman N El Kadi S et al Determination and Interpretation of the QT Interval Circulation 2018 138 2345 2358 30571576
[64] Postema PG De Jong JSSG Van der Bilt IAC Wilde AAM Accurate electrocardiographic assessment of the QT interval: teach the tangent Heart Rhythm 2008 5 1015 1018 18598957
[65] Bazett HC An Analysis of the Time-Relations of Heart 1920 7 353
[66] Fridericia LS Die Systolendauer im Elekrokardiogramm bei normalen Menschen und bei Herzkranken Acta Medica Scandinavica 1920 53 469 486
[67] Viskin S Postema PG Bhuiyan ZA Rosso R Kalman JM Vohra JK et al The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome Journal of the American College of Cardiology 2010 55 1955 1961 20116193
[68] Vink AS Hermans BJM Hooglugt JLQ Peltenburg PJ Meijborg VMF Hofman N et al Diagnostic Accuracy of the Standing Test in Adults Suspected for Congenital Long-QT Syndrome Journal of the American Heart Association 2023 12 e026419 37421262
[69] Gollob MH Redpath CJ Roberts JD The short QT syndrome: proposed diagnostic criteria Journal of the American College of Cardiology 2011 57 802 812 21310316
[70] Groeneveld SA van der Ree MH Taha K de Bruin-Bon RHA Cramer MJ Teske AJ et al Echocardiographic deformation imaging unmasks global and regional mechanical dysfunction in patients with idiopathic ventricular fibrillation: A multicenter case-control study Heart Rhythm 2021 18 1666 1672 34058391
[71] Cabanelas N Vidigal Ferreira MJ Donato P Gaspar A Pinto J Caseiro-Alves F et al Added value of cardiac magnetic resonance in etiological diagnosis of ventricular arrhythmias Revista Portuguesa De Cardiologia: Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology: an Official Journal of the Portuguese Society of Cardiology 2013 32 785 791 24060468
[72] Neilan TG Farhad H Mayrhofer T Shah RV Dodson JA Abbasi SA et al Late gadolinium enhancement among survivors of sudden cardiac arrest JACC. Cardiovascular Imaging 2015 8 414 423 25797123
[73] Smith ED Lakdawala NK Papoutsidakis N Aubert G Mazzanti A McCanta AC et al Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct from Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy Circulation 2020 141 1872 1884 32372669
[74] Basso C Iliceto S Thiene G Perazzolo Marra M Mitral Valve Prolapse, Ventricular Arrhythmias, and Sudden Death Circulation 2019 140 952 964 31498700
[75] Düren DR Becker AE Dunning AJ Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: a prospective study Journal of the American College of Cardiology 1988 11 42 47 3335704
[76] Delling FN Aung S Vittinghoff E Dave S Lim LJ Olgin JE et al Antemortem and Post-Mortem Characteristics of Lethal Mitral Valve Prolapse Among All Countywide Sudden Deaths JACC. Clinical Electrophysiology 2021 7 1025 1034 33640349
[77] Basso C Perazzolo Marra M Rizzo S De Lazzari M Giorgi B Cipriani A et al Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death Circulation 2015 132 556 566 26160859
[78] Groeneveld SA Kirkels FP Cramer MJ Evertz R Haugaa KH Postema PG et al Prevalence of Mitral Annulus Disjunction and Mitral Valve Prolapse in Patients with Idiopathic Ventricular Fibrillation Journal of the American Heart Association 2022 11 e025364 35929463
[79] Freed LA Levy D Levine RA Larson MG Evans JC Fuller DL et al Prevalence and clinical outcome of mitral-valve prolapse The New England Journal of Medicine 1999 341 1 7 10387935
[80] Fulton BL Liang JJ Enriquez A Garcia FC Supple GE Riley MP et al Imaging characteristics of papillary muscle site of origin of ventricular arrhythmias in patients with mitral valve prolapse Journal of Cardiovascular Electrophysiology 2018 29 146 153 29059484
[81] Levine RA Stathogiannis E Newell JB Harrigan P Weyman AE Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality Journal of the American College of Cardiology 1988 11 1010 1019 3281989
[82] Faletra FF Leo LA Paiocchi VL Caretta A Viani GM Schlossbauer SA et al Anatomy of mitral annulus insights from non-invasive imaging techniques European Heart Journal. Cardiovascular Imaging 2019 20 843 857 31219549
[83] Todica A Siebermair J Schiller J Zacherl MJ Fendler WP Massberg S et al Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: An 123I-metaiodobenzylguanidine SPECT/CT study Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 2020 27 2402 2409 30560521
[84] Siebermair J Lehner S Sattler SM Rizas KD Beckmann BM Becker A et al Left-ventricular innervation assessed by 123I-SPECT/CT is associated with cardiac events in inherited arrhythmia syndromes International Journal of Cardiology 2020 312 129 135 32201099
[85] Wang YS Scheinman MM Chien WW Cohen TJ Lesh MD Griffin JC Patients with supraventricular tachycardia presenting with aborted sudden death: incidence, mechanism and long-term follow-up Journal of the American College of Cardiology 1991 18 1711 1719 1960318
[86] Brembilla-Perrot B Marçon O Chometon F Bertrand J Terrier de la Chaise A Louis P et al Supraventricular tachyarrhythmia as a cause of sudden cardiac arrest Journal of Interventional Cardiac Electrophysiology: an International Journal of Arrhythmias and Pacing 2006 16 97 104 17103314
[87] Haïssaguerre M Hocini M Cheniti G Duchateau J Sacher F Puyo S et al Localized Structural Alterations Underlying a Subset of Unexplained Sudden Cardiac Death Circulation. Arrhythmia and Electrophysiology 2018 11 e006120 30002064
[88] Giudicessi JR Ackerman MJ Exercise testing oversights underlie missed and delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia in young sudden cardiac arrest survivors Heart Rhythm 2019 16 1232 1239 30763784
[89] Roston TM Kallas D Davies B Franciosi S De Souza AM Laksman ZW et al Burst Exercise Testing Can Unmask Arrhythmias in Patients with Incompletely Penetrant Catecholaminergic Polymorphic Ventricular Tachycardia JACC. Clinical Electrophysiology 2021 7 437 441 33888264
[90] Walker BD Krahn AD Klein GJ Skanes AC Yee R Burst bicycle exercise facilitates diagnosis of latent long QT syndrome American Heart Journal 2005 150 1059 1063 16290996
[91] Wong JA Gula LJ Klein GJ Yee R Skanes AC Krahn AD Utility of treadmill testing in identification and genotype prediction in long-QT syndrome Circulation. Arrhythmia and Electrophysiology 2010 3 120 125 20071715
[92] Schwartz PJ Crotti L QTc behavior during exercise and genetic testing for the long-QT syndrome Circulation 2011 124 2181 2184 22083145
[93] Collet JP Thiele H Barbato E Barthélémy O Bauersachs J Bhatt DL et al 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation European Heart Journal 2021 42 1289 1367 32860058
[94] Conte G de Asmundis C Ciconte G Julià J Sieira J Chierchia GB et al Follow-up from childhood to adulthood of individuals with family history of Brugada syndrome and normal electrocardiograms JAMA 2014 312 2039 2041 25399282
[95] Zaya M Mehta PK Merz CNB Provocative testing for coronary reactivity and spasm Journal of the American College of Cardiology 2014 63 103 109 24201078
[96] Abdalla IS Prineas RJ Neaton JD Jacobs DR Jr Crow RS Relation between ventricular premature complexes and sudden cardiac death in apparently healthy men The American Journal of Cardiology 1987 60 1036 1042 3673904
[97] Sitorus GDS Ragab AAY Houck CA Lanters EAH Heida A van Gastel VE et al Ventricular Dysrhythmias During Long-Term Follow-Up in Patients with Inherited Cardiac Arrhythmia The American Journal of Cardiology 2019 124 1436 1441 31481179
[98] Friedlander Y Siscovick DS Weinmann S Austin MA Psaty BM Lemaitre RN et al Family history as a risk factor for primary cardiac arrest Circulation 1998 97 155 160 9445167
[99] Jouven X Desnos M Guerot C Ducimetière P Predicting sudden death in the population: the Paris Prospective Study I Circulation 1999 99 1978 1983 10209001
[100] Dekker LRC Bezzina CR Henriques JPS Tanck MW Koch KT Alings MW et al Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients Circulation 2006 114 1140 1145 16940195
[101] Wilde AAM Semsarian C Márquez MF Shamloo AS Ackerman MJ Ashley EA et al European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology 2022 24 1307 1367 35373836
[102] Mellor G Laksman ZWM Tadros R Roberts JD Gerull B Simpson CS et al Genetic Testing in the Evaluation of Unexplained Cardiac Arrest: From the CASPER (Cardiac Arrest Survivors with Preserved Ejection Fraction Registry) Circulation. Cardiovascular Genetics 2017 10 e001686 28600387
[103] Asatryan B Schaller A Seiler J Servatius H Noti F Baldinger SH et al Usefulness of Genetic Testing in Sudden Cardiac Arrest Survivors with or Without Previous Clinical Evidence of Heart Disease The American Journal of Cardiology 2019 123 2031 2038 30975432
[104] Vittoria Matassini M Krahn AD Gardner M Champagne J Sanatani S Birnie DH et al Evolution of clinical diagnosis in patients presenting with unexplained cardiac arrest or syncope due to polymorphic ventricular tachycardia Heart Rhythm 2014 11 274 281 24239842
[105] Verheul LM van der Ree MH Groeneveld SA Mulder BA Christiaans I Kapel GFL et al The genetic basis of apparently idiopathic ventricular fibrillation: a retrospective overview Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology 2023 25 euad336 37967257
[106] Schwartz PJ Stramba-Badiale M Crotti L Pedrazzini M Besana A Bosi G et al Prevalence of the congenital long-QT syndrome Circulation 2009 120 1761 1767 19841298
[107] Adler A Novelli V Amin AS Abiusi E Care M Nannenberg EA et al An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome Circulation 2020 141 418 428 31983240
[108] Priori SG Napolitano C Tiso N Memmi M Vignati G Bloise R et al Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia Circulation 2001 103 196 200 11208676
[109] Laitinen PJ Brown KM Piippo K Swan H Devaney JM Brahmbhatt B et al Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia Circulation 2001 103 485 490 11157710
[110] Crotti L Spazzolini C Tester DJ Ghidoni A Baruteau AE Beckmann BM et al Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry European Heart Journal 2019 40 2964 2975 31170290
[111] Clemens DJ Tester DJ Giudicessi JR Bos JM Rohatgi RK Abrams DJ et al International Triadin Knockout Syndrome Registry Circulation. Genomic and Precision Medicine 2019 12 e002419 30649896
[112] Lahat H Pras E Eldar M A missense mutation in CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel Annals of Medicine 2004 36 87 91 15176429
[113] Roux-Buisson N Cacheux M Fourest-Lieuvin A Fauconnier J Brocard J Denjoy I et al Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human Human Molecular Genetics 2012 21 2759 2767 22422768
[114] Devalla HD Gélinas R Aburawi EH Beqqali A Goyette P Freund C et al TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT EMBO Molecular Medicine 2016 8 1390 1408 27861123
[115] Webster G Aburawi EH Chaix MA Chandler S Foo R Islam AKMM et al Life-threatening arrhythmias with autosomal recessive TECRL variants Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology 2021 23 781 788 33367594
[116] Giudicessi JR Lieve KVV Rohatgi RK Koca F Tester DJ van der Werf C et al Assessment and Validation of a Phenotype-Enhanced Variant Classification Framework to Promote or Demote RYR2 Missense Variants of Uncertain Significance Circulation. Genomic and Precision Medicine 2019 12 e002510 31112425
[117] Probst V Wilde AAM Barc J Sacher F Babuty D Mabo P et al SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome Circulation. Cardiovascular Genetics 2009 2 552 557 20031634
[118] Herman ARM Cheung C Gerull B Simpson CS Birnie DH Klein GJ et al Outcome of Apparently Unexplained Cardiac Arrest: Results from Investigation and Follow-Up of the Prospective Cardiac Arrest Survivors with Preserved Ejection Fraction Registry Circulation. Arrhythmia and Electrophysiology 2016 9 e003619 26783233
